Se Ryeon Lee

636 total citations
53 papers, 417 citations indexed

About

Se Ryeon Lee is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Se Ryeon Lee has authored 53 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 15 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Se Ryeon Lee's work include Acute Myeloid Leukemia Research (8 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Neutropenia and Cancer Infections (7 papers). Se Ryeon Lee is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Neutropenia and Cancer Infections (7 papers). Se Ryeon Lee collaborates with scholars based in South Korea, Japan and United States. Se Ryeon Lee's co-authors include Anne J. McNeil, Hwa Jung Sung, Yong Park, Chul Won Choi, Jacob W. G. Bloom, Byung Soo Kim, Steven E. Wheeler, Dae Sik Kim, Ka‐Won Kang and Zachary J. Bryan and has published in prestigious journals such as Blood, PLoS ONE and Scientific Reports.

In The Last Decade

Se Ryeon Lee

47 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Se Ryeon Lee South Korea 13 113 107 86 69 54 53 417
E. Jacobsen Norway 16 222 2.0× 73 0.7× 37 0.4× 29 0.4× 18 0.3× 39 729
JS Huang Germany 8 58 0.5× 79 0.7× 39 0.5× 47 0.7× 21 0.4× 12 419
Christine Hofmann Germany 21 110 1.0× 300 2.8× 95 1.1× 81 1.2× 25 0.5× 52 1.3k
L Brookman Switzerland 11 46 0.4× 151 1.4× 37 0.4× 109 1.6× 42 0.8× 18 656
Guolin Yuan China 15 147 1.3× 336 3.1× 298 3.5× 12 0.2× 60 1.1× 43 847
Michelle Kuzma Canada 12 42 0.4× 133 1.2× 135 1.6× 20 0.3× 26 0.5× 19 509
Yuki Nishida Japan 13 117 1.0× 224 2.1× 202 2.3× 47 0.7× 22 0.4× 68 547
Elly Barry United States 12 308 2.7× 157 1.5× 310 3.6× 22 0.3× 88 1.6× 24 1.2k
Richard A. Mann United States 14 34 0.3× 89 0.8× 69 0.8× 21 0.3× 13 0.2× 43 559
Li Fu China 13 45 0.4× 249 2.3× 57 0.7× 61 0.9× 6 0.1× 40 674

Countries citing papers authored by Se Ryeon Lee

Since Specialization
Citations

This map shows the geographic impact of Se Ryeon Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Se Ryeon Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Se Ryeon Lee more than expected).

Fields of papers citing papers by Se Ryeon Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Se Ryeon Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Se Ryeon Lee. The network helps show where Se Ryeon Lee may publish in the future.

Co-authorship network of co-authors of Se Ryeon Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Se Ryeon Lee. A scholar is included among the top collaborators of Se Ryeon Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Se Ryeon Lee. Se Ryeon Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kim, Suhyeon, Ji Ye Jung, Seo-Yeon Ahn, et al.. (2024). Risk stratification for early mortality in newly diagnosed acute promyelocytic leukemia: a multicenter, non-selected, retrospective cohort study. Frontiers in Oncology. 14. 1307315–1307315. 1 indexed citations
3.
Baek, Dong Won, Han‐Seung Park, Sang Kyun Sohn, et al.. (2023). Rituximab plus multiagent chemotherapy for newly diagnosed CD20-positive acute lymphoblastic leukemia: a prospective phase II study. The Korean Journal of Internal Medicine. 38(5). 734–746. 5 indexed citations
4.
5.
Kang, Ka‐Won, Dae Sik Kim, Se Ryeon Lee, et al.. (2021). The effect of the response to the coronavirus disease pandemic on treatment outcomes in patients with lymphoma and multiple myeloma. The Korean Journal of Internal Medicine. 36(6). 1459–1470.
6.
Kang, Ka‐Won, Dae Sik Kim, Se Ryeon Lee, et al.. (2020). Comparison between 5-day decitabine and 7-day azacitidine for lower-risk myelodysplastic syndromes with poor prognostic features: a retrospective multicentre cohort study. Scientific Reports. 10(1). 39–39. 11 indexed citations
7.
Kang, Ka‐Won, Se Ryeon Lee, Dae Sik Kim, et al.. (2018). Lack of usefulness of computed tomography for surveillance in patients with aggressive non-Hodgkin lymphoma. PLoS ONE. 13(2). e0192656–e0192656. 1 indexed citations
8.
Lee, Se Ryeon, Ka‐Won Kang, Dae Sik Kim, et al.. (2018). Modified dose of melphalan-prednisone in multiple myeloma patients receiving bortezomib plus melphalan-prednisone treatment. The Korean Journal of Internal Medicine. 34(6). 1333–1346. 1 indexed citations
9.
10.
Sung, Hwa Jung, Se Ryeon Lee, In Keun Choi, et al.. (2015). Imatinib Mesylate Dose Adjustment Based on Body Surface Area for CML Chronic Phase Patients Intolerant to Standard Dosage. Acta Haematologica. 134(1). 59–68. 3 indexed citations
11.
Kim, Dae Sik, Ka‐Won Kang, Se Ryeon Lee, et al.. (2015). Comparison of consolidation strategies in acute myeloid leukemia: high-dose cytarabine alone versus intermediate-dose cytarabine combined with anthracyclines. Annals of Hematology. 94(9). 1485–1492. 13 indexed citations
12.
Kang, Byung Woog, Sang Kyun Sohn, Joon Ho Moon, et al.. (2014). Clinical features and treatment outcomes in patients with mantle cell lymphoma in Korea: Study by the Consortium for Improving Survival of Lymphoma. Blood Research. 49(1). 15–15. 15 indexed citations
13.
Kim, Dae Sik, Ka‐Won Kang, Hong Jun Kim, et al.. (2014). Selection of Elderly Acute Myeloid Leukemia Patients for Intensive Chemotherapy: Effectiveness of Intensive Chemotherapy and Subgroup Analysis. Acta Haematologica. 133(3). 300–309. 6 indexed citations
14.
15.
Lee, Se Ryeon, Jacob W. G. Bloom, Steven E. Wheeler, & Anne J. McNeil. (2013). Accelerating Ni(ii) precatalyst initiation using reactive ligands and its impact on chain-growth polymerizations. Dalton Transactions. 42(12). 4218–4218. 36 indexed citations
16.
Lee, Suk‐young, Se Ryeon Lee, Won Jin Chang, et al.. (2012). Successful treatment of disseminated interdigitating dendritic cell sarcoma with adriamycin, bleomycin, vinblastine, and dacarbazine chemotherapy. The Korean Journal of Hematology. 47(2). 150–150. 13 indexed citations
17.
Park, Yong, Seung Jin Lee, In Young Choi, et al.. (2011). Human Feeder Cells Can Support the Undifferentiated Growth of Human and Mouse Embryonic Stem Cells Using Their Own Basic Fibroblast Growth Factors. Stem Cells and Development. 20(11). 1901–1910. 24 indexed citations
18.
Park, Yong, Yoon Ji Choi, Se Ryeon Lee, et al.. (2011). Pretreatment Serum Level of 15-kDa Granulysin Might Have a Prognostic Value in Patients with Diffuse Large B Cell Lymphoma. Acta Haematologica. 126(2). 79–86. 4 indexed citations
19.
Park, Yong, Dae Sik Kim, Se Ryeon Lee, et al.. (2009). The suggestion of a risk stratification system for febrile neutropenia in patients with hematologic disease. Leukemia Research. 34(3). 294–300. 15 indexed citations
20.
Lee, Se Ryeon, et al.. (2008). All-trans Retinoic Acid-induced Nephrotic-range Proteinuria in a Patient with Acute Promyelocytic Leukemia. The Korean Journal of Hematology. 43(3). 166–166. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Jacobsen Breakdown of academic impact, for papers by JS Huang Breakdown of academic impact, for papers by Christine Hofmann Breakdown of academic impact, for papers by L Brookman Breakdown of academic impact, for papers by Guolin Yuan Breakdown of academic impact, for papers by Michelle Kuzma Breakdown of academic impact, for papers by Yuki Nishida Breakdown of academic impact, for papers by Elly Barry Breakdown of academic impact, for papers by Richard A. Mann Breakdown of academic impact, for papers by Li Fu
Rankless by CCL
2026